Diosgenin protects against cationic bovine serum albumin-induced membranous glomerulonephritis by attenuating oxidative stress and renal inflammation via the NF- κB pathway
CONCLUSIONS: The results suggest a potential therapeutic benefit of DG against MGN due to the inhibition of the NF-κB pathway, supporting the need for further clinical trials.PMID:38516898 | DOI:10.1080/13880209.2024.2330602
Source: Pharmaceutical Biology - Category: Drugs & Pharmacology Authors: Shiyan Jia Ruihua Si Guangzhen Liu Qiming Zhong Source Type: research
More News: Antidoxidants | Biology | Clinical Trials | Drugs & Pharmacology | Glomerulonephritis | Nephrotic Syndrome | Translocation | Urology & Nephrology